{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:15:39Z","timestamp":1792718139329,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2314-B-037-083-MY3"],"award-info":[{"award-number":["MOST 107-2314-B-037-083-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC108A04-3"],"award-info":[{"award-number":["KMU-TC108A04-3"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC109B05"],"award-info":[{"award-number":["KMU-TC109B05"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH106-6R08"],"award-info":[{"award-number":["KMUH106-6R08"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH107-7R05"],"award-info":[{"award-number":["KMUH107-7R05"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12072-021-10242-2","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T13:02:51Z","timestamp":1628773371000},"page":"1136-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients"],"prefix":"10.1007","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct01068444","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-7051","authenticated-orcid":false,"given":"Jee-Fu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chien","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Lun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yau","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jong","family":"Bair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Jen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-I","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Cheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yen","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Chern","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Yau","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Lung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Long","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"issue":"8","key":"10242_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/lt.21126","volume":"13","author":"M Laryea","year":"2007","unstructured":"Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007;13(8):1109\u20131114","journal-title":"Liver Transpl"},{"issue":"1","key":"10242_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jfma.2019.03.014","volume":"119","author":"JF Huang","year":"2020","unstructured":"Huang JF, Tsai PC, Yeh ML, Huang CF, Huang CI, Hsieh MH, et al. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. J Formos Med Assoc 2020;119(1):89\u201396","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"10242_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/apt.15673","volume":"51","author":"C Estes","year":"2020","unstructured":"Estes C, Chan HL, Chien RN, Chuang WL, Fung J, Goh GB-B, et al. Modelling NAFLD disease burden in four Asian regions\u20142019-2030. Aliment Pharmacol Ther 2020;51(8):801\u2013811","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10242_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10900-013-9792-8","volume":"39","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Chou C, Sinha SR, Kamal A, Ahmed A. Ethnic disparities in the association of body mass index with the risk of hypertension and diabetes. J Commun Health 2014;39(3):437\u2013445","journal-title":"J Commun Health"},{"issue":"1","key":"10242_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2350-14-54","volume":"14","author":"PJ Hsiao","year":"2013","unstructured":"Hsiao PJ, Chen ZC, Hung WW, Yang YHC, Lee MY, Huang JF, et al. Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C> G) in the development of fatty liver. BMC Med Genet 2013;14(1):54","journal-title":"BMC Med Genet"},{"issue":"6","key":"10242_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017;66(6):1138\u20131153","journal-title":"Gut"},{"issue":"2","key":"10242_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/MEG.0000000000001285","volume":"31","author":"TY Lin","year":"2019","unstructured":"Lin TY, Yeh ML, Huang CF, Huang CI, Dai CY, Hsieh MH, et al. Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies. Eur J Gastroenterol Hepatol 2019;31(2):224\u2013229","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10242_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","volume":"66","author":"Y Rotman","year":"2017","unstructured":"Rotman Y, Sanyal AJ. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut 2017;66(1):180\u2013190","journal-title":"Gut"},{"issue":"22","key":"10242_CR9","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa060326","volume":"355","author":"R Belfort","year":"2006","unstructured":"Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006;355(22):2297\u20132307","journal-title":"N Engl J Med"},{"issue":"4","key":"10242_CR10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","volume":"135","author":"GP Aithal","year":"2008","unstructured":"Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008;135(4):1176\u20131184","journal-title":"Gastroenterology"},{"issue":"2","key":"10242_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.clnu.2009.08.008","volume":"29","author":"LR Anastacio","year":"2010","unstructured":"Anastacio LR, Lima AS, Toulson Davisson Correia MI. Metabolic syndrome and its components after liver transplantation: incidence, prevalence, risk factors, and implications. Clin Nutr 2010;29(2):175\u2013179","journal-title":"Clin Nutr"},{"issue":"7","key":"10242_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"D Matthews","year":"1985","unstructured":"Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412\u2013419","journal-title":"Diabetologia"},{"issue":"1","key":"10242_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67(1):328\u2013357","journal-title":"Hepatology"},{"issue":"4","key":"10242_CR14","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/hep.30782","volume":"70","author":"M Rinella","year":"2019","unstructured":"Rinella M, Tacke F, Sanyal A, Anstee Q. Report on the AASLD\/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD. Hepatology (Baltimore, MD) 2019;70(4):1424","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"6","key":"10242_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 2006;43(6):1317\u20131325","journal-title":"Hepatology"},{"issue":"2","key":"10242_CR16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, Bril F, Cusi K, Newsome PN. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology 2019;70(2):711\u2013724","journal-title":"Hepatology"},{"issue":"10","key":"10242_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s12325-009-0072-z","volume":"26","author":"LL Stein","year":"2009","unstructured":"Stein LL, Dong MH, Loomba R. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status. Adv Ther 2009;26(10):893","journal-title":"Adv Ther"},{"issue":"18","key":"10242_CR18","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362(18):1675\u20131685","journal-title":"N Engl J Med"},{"issue":"5","key":"10242_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/M15-1774","volume":"165","author":"K Cusi","year":"2016","unstructured":"Cusi K, Orsak B, Bril F, Lomonaco R, Hecht J, Ortiz-Lopez C, et al. Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial. Ann Intern Med 2016;165(5):305\u2013315","journal-title":"Ann Intern Med"},{"issue":"8","key":"10242_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cgh.2006.05.005","volume":"4","author":"G Lutchman","year":"2006","unstructured":"Lutchman G, Promrat K, Kleiner DE, Heller T, Ghany MG, Yanovski JA, et al. Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement. Clin Gastroenterol Hepatol 2006;4(8):1048\u20131052","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10242_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jhep.2019.04.019","volume":"71","author":"ME Rinella","year":"2019","unstructured":"Rinella ME, Tacke F, Sanyal AJ, Anstee QM. Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD. J Hepatol 2019;71(4):823\u2013833","journal-title":"J Hepatol"},{"issue":"5","key":"10242_CR22","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/hep.30672","volume":"70","author":"A Cheung","year":"2019","unstructured":"Cheung A, Neuschwander-Tetri BA, Kleiner DE, Schabel E, Rinella M, Harrison S, et al. Defining improvement in nonalcoholic steatohepatitis for treatment trial endpoints: recommendations from the liver forum. Hepatology 2019;70(5):1841\u20131855","journal-title":"Hepatology"},{"key":"10242_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/hep.31122","volume":"72","author":"JF Huang","year":"2020","unstructured":"Huang JF, Dai CY, Yu ML, Chuang WL. Letter to the editors: regional epidemics of nonalcoholic fatty liver disease: timing of westernization and ethnicity matter. Hepatology 2020;72:781","journal-title":"Hepatology"},{"issue":"4","key":"10242_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jceh.2012.10.010","volume":"2","author":"BC Sharma","year":"2012","unstructured":"Sharma BC, Kumar A, Garg V, Reddy RS, Sakhuja P, Sarin SK. A Randomized controlled trial comparing efficacy of pentoxifylline and pioglitazone on metabolic factors and liver histology in patients with non-alcoholic steatohepatitis. J Clin Exp Hepatol 2012;2(4):333\u2013337","journal-title":"J Clin Exp Hepatol"},{"issue":"9403","key":"10242_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"EC Who","year":"2004","unstructured":"Who EC. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (London, England) 2004;363(9403):157","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10242_CR26","first-page":"216","volume":"5","author":"R Kumar","year":"2017","unstructured":"Kumar R, Mohan S. Non-alcoholic fatty liver disease in lean subjects: characteristics and implications. J Clin Transl Hepatol 2017;5(3):216","journal-title":"J Clin Transl Hepatol"},{"issue":"10","key":"10242_CR27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/j.1440-1746.2012.07222.x","volume":"27","author":"CJ Liu","year":"2012","unstructured":"Liu CJ. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol 2012;27(10):1555\u20131560","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10242_CR28","doi-asserted-by":"publisher","first-page":"e0139796","DOI":"10.1371\/journal.pone.0139796","volume":"10","author":"J-F Huang","year":"2015","unstructured":"Huang J-F, Yeh M-L, Yu M-L, Huang C-F, Dai C-Y, Hsieh M-Y, et al. Hyperuricemia inversely correlates with disease severity in Taiwanese nonalcoholic steatohepatitis patients. PLoS One 2015;10(10):e0139796","journal-title":"PLoS One"},{"issue":"1","key":"10242_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.febslet.2007.07.084","volume":"582","author":"P-D Denechaud","year":"2008","unstructured":"Denechaud P-D, Dentin R, Girard J, Postic C. Role of ChREBP in hepatic steatosis and insulin resistance. FEBS Lett 2008;582(1):68\u201373","journal-title":"FEBS Lett"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10242-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10242-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10242-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T03:40:53Z","timestamp":1699328453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10242-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10242"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10242-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-596467\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jee-Fu Huang: Consultant of Roche, BMS, Gilead, Merck, Sysmex, Pharmaessential, Polaris, and Instylla. Speaker for Abbvie, BMS, Gilead, Merck, Sysmex, and Roche. Chia-Yen Dai: Consultant of Abbvie and Roche; Speaker for Abbvie, Gilead, and Roche. Chung-Feng Huang: Speaker for Abbvie, BMS, Bayer, Gilead, Merck, and Roche. Ming-Lung Yu: Research grant from Abbott, BMS, Merck, and Gilead; Consultant of Abbvie, Abbott, Ascletis, BMS, Merck, Gilead, and Roche; Speaker for Abbvie, Abbott, BMS, Merck, Gilead, and IPSEN. Wan-Long Chuang: Consultant of Gilead, AbbVie, BMS, and PharmaEssentia; Speaker for Gilead, AbbVie, BMS, and PharmaEssentia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of the Kaohsiung Medical University Hospital approved the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The trial was conducted in compliance with the Declaration of Helsinki and the Good Clinical Practice guidelines of the International Conference on Harmonization. Written informed consent for interview, anthropomorphic measurements, blood sampling, liver biopsies and medical record review were obtained from patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors contributed to the interpretation of the data and reviewed and approved the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}